Daniel Abramovicz

Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2002 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, D. D’Cruz et al. · Annals of the Rheumatic Diseases · 2009 · 540 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement

Francesco Locatelli, Peter Bárány, Adrian Covic et al. · Nephrology Dialysis Transplantation · 2013 · 472 citations · Full text

Medicine, Hematology, Nephrology +12

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2004 · 387 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

European Best Practice Guidelines for Renal Transplantation (Part 2).

F. Berthoux, Daniel Abramovicz, Henrik Ekberg et al. · Lund University Publications (Lund University) · 2002 · 372 citations

Medicine, Nephrology, Surgery +16